Global Cholera Treatment Market - Industry Trends and Forecast to 2026

  • Pharmaceutical
  • Upcoming Report
  • Oct 2019
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Cholera Treatment Market By Treatment (Medication, Vaccinations), Drugs (Tetracycline, Quinolones and Others), Vaccine (Dukoral, Shanchol, Vaxchora and Others), Route of Administration (Oral, Injectable), End- Users (Hospitals, Homecare, Specialty Clinics, Primary Care Provider and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026

Market Analysis: Global Cholera Treatment Market

Global Cholera treatment market is expected to grow at a substantial CAGR in the forecast period of 2019-2026. Emergence of drugs used to treat risk associated with tularemia Infection and high demand of disease specific novel therapies are the key factors that fueling the market growth

Market Definition: Global Cholera Treatment Market

Cholera is an infectious disease caused by the gram-negative bacteria Vibrio cholera found in food or water contaminated by feces from a person with the infection. It causes severe watery diarrhea which can eventually lead to dehydration and even death if untreated. It is more prevalent in children than adults. People with cholera often experience rapid heartbeat, Loss of skin elasticity, watery stool 

According to the statistics published by WHO in 2017, an estimated prevalence of cholera is approximately 1.3 to 4.0 million and 21,000 to 143,000 deaths occur globally. Growing cases of cholera infection worldwide and recently launch of product is fueling market growth.

Market Drivers

  • Growing prevalence of cholera infection and consumption of contaminated food is boosting the market growth
  • High demand of disease specific novel treatment can also act as a market driver
  • Huge financial support to the researchers for developing novel intervention is boosting the market growth
  • Development of novel approaches for new cholera vaccine is also drive the market growth

Market Restraints

  • Limited operating revenue opportunities for research and development of targeted therapies by many pharmaceuticals is acting as a challenging factor for the growth of this market
  • Low healthcare budget in some developing countries is hamper the market growth

Segmentation: Global Cholera Treatment Market

By Treatment

  • Medication
  • Vaccinations

By Drugs

  • Tetracycline

    • Doxycycline
    • Minocycline

  • Quinolones

    • Ciprofloxacin
    • Levofloxacin

  • Others

By Vaccine

  • Dukoral
  • Shanchol
  • Vaxchora
  • Others

By Route of Administration

  • Oral
  • Injectable

 By End Users

  • Hospitals
  • Homecare
  • Primary Care Provider
  • Specialty Clinics
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • South America

    • Brazil
    • Rest of South America

  • Europe

    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Thailand
    • Malaysia
    • Indonesia
    • Philippines
    • Rest of Asia Pacific

  • Middle East & Africa

    • South Africa
    • Rest of Middle East & Africa

Key Developments in the Market:

  • In October 2016, PaxVax, Inc a subsidiary of Emergent BioSolutions Inc received an approval from the FDA for Vaxchora, a single-dose vaccine for active immunization against cholera. The approval of Vaxchora, represents a major advance in the protection of these patients through a targeted mode of action.
  • In June 2016 Astellas Pharma Inc in collaboration with The Institute of Medical Science at the University of Tokyo is developing rice-based oral vaccine against cholera and E. coli-related diarrheal diseases. If trial successful, it will significantly improve the treatment landscape from existing cholera vaccine.

Competitive Analysis:

Global cholera treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global cholera treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Players:

Few of the major competitors currently working in the global cholera treatment market are Valneva SE, Sanofi, Emergent BioSolutions Inc, EUBIOLOGICS CO., LTD,  Astellas Pharma Inc, Johnson & Johnson Services, Inc, Celldex Therapeutics, GlaxoSmithKline plc, Merck & Co., Inc, Sun Pharmaceutical Industries Ltd, Fresenius Kabi AG, Teva Pharmaceutical Industries Ltd, Novartis AG, Pfizer Inc and others

Research Methodology: Global Cholera Treatment Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global cholera treatment market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions